News and information about universal access to health care; the impact of restrictive policies and financial challenges on access to treatment; drug stock-outs; and scaling up services.

Access to medicines and treatment: latest news

Access to medicines and treatment resources

Access to medicines and treatment features

Access to medicines and treatment news from aidsmap

More news

Access to medicines and treatment news selected from other sources

  • Bringing Down the House on Intellectual Property and Access

    As the Trump administration makes noise about the high price of pharmaceuticals while doubling down on its commitment to “protect the engine of American ingenuity,” this issue of TAGline dives deep into the rhetoric and realities of intellectual property (IP) protections and the current wave of political shenanigans on critical drugs, surfacing the fundamental lies and vested interests that deny medication to those in need in the United States and around the world.

    9 hours ago | Treatment Action Group
  • Asylum seekers in Britain unable to access healthcare

    Cost and fears about how they will be treated, or consequences for their immigration status, are preventing people seeking or refused asylum from using health services, a new report from the Equality and Human Rights Commission has found, prompting a call for greater separation of the immigration and healthcare systems.

    30 November 2018 | Equality and Human Rights Commission
  • Trump Wants to Restrict Access to HIV Meds for People on Medicare

    In a move to cut Medicare costs, the proposed changes would also affect people with cancer, depression and schizophrenia.

    29 November 2018 | Poz
  • MSF: Pharmaceutical corporations failing children with HIV

    Developing countries are struggling to provide HIV-positive children with World Health Organization (WHO)-recommended treatments because pediatric versions of HIV medicines don’t exist, are priced out of reach, or haven’t been registered in all countries that need them, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) ahead of a Vatican City meeting of HIV stakeholders on scaling up diagnosis and treatment for children.

    29 November 2018 | Doctors Without Borders
  • New HIV testing centers open in the Philippines as HIV crisis worsens

    More HIV testing centers have opened in the Philippines as the country struggles to curb the growing number of new cases. Already this year there have been more than 7,600 new HIV diagnosis in the Philippines. The south-east Asian nation has experienced a 174% increase in new infections since 2010. LoveYourself is an organisation mostly made up of volunteers who take multi-layered action on the HIV epidemic through promoting self-worth.

    16 November 2018 | Gay Star News
  • NHS denied treatment for migrants who can’t afford upfront charges

    Treatment deemed urgent or “immediately necessary” is meant to still be carried out regardless of ability to pay. However, the Guardian has learned of a patient with an advanced form of blood cancer who was denied urgent chemotherapy after the hospital demanded upfront payment.

    14 November 2018 | The Guardian
  • Bedaquiline price protests hit World Lung Conference launch

    As the opening ceremony of the 49th Union World Conference on Lung Health kicked off in the Netherlands last night, protesting activists demanded Johnson & Johnson (J&J) slash its price for the blockbuster tuberculosis (TB) drug, bedaquiline.

    26 October 2018 | Health-e
  • Patients 'may need to stockpile own drugs if no-deal Brexit looms'

    Patients should consider stockpiling their own drugs if it looks likely the UK will leave the EU with no deal, the pharmaceuticals industry has said, telling MPs that such a scenario could be “catastrophic” for medicine supplies and necessitate emergency powers.

    23 October 2018 | The Guardian
  • Johnson & Johnson prices keep key TB medicines out of reach

    As US pharmaceutical corporation Johnson & Johnson (J&J) continues to charge high prices for its newer tuberculosis (TB) drug bedaquiline, people with drug-resistant tuberculosis (DR-TB) are forced to go without the best possible treatments, according to a new report—DR-TB Drugs Under the Microscope—released today by Doctors Without Borders/Médecins Sans Frontières (MSF) at the 49th Union World Conference on Lung Health in The Hague. J&J should cut the price of bedaquiline in half so more lives can be saved, said the international medical humanitarian organization MSF.

    23 October 2018 | MSF
  • The health innovation system is ‘broken’ and failing patients

    NHS patients are being let down by a global health innovation system which fails to deliver the treatments they need at prices that government can afford, according to a new report led by Professor Mariana Mazzucato, Director of the UCL Institute for Innovation and Public Purpose (IIPP), in collaboration with STOPAIDS, Global Justice Now and Just Treatment.

    18 October 2018 | STOP AIDS
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.